- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07490145
Trauma Activation Criteria
March 18, 2026 updated by: Methodist Health System
Trauma Activation Criteria Refinement
To quantify the over- and under-triage rates as relative to trauma activation criteria reform.
Study Overview
Detailed Description
Accurately identifying the patients requiring additional care through trauma resources drives effective resource management and quality patient care.
Determining the criteria used to activate the trauma team is an essential means of managing hospital resource utilization.
These criteria are based off of injury patterns, physiological findings, and mechanism of injury to predict the level of care and resource consumption.Pre-hospital criteria, however, have been described as having poor sensitivity, especially in older patients.
While over-activation of trauma teams potentially reduces available resources for other patients, data suggest there is minimal risk of harm to the patient.
The standardized triage assessment tool has been shown to outperform other triage assessment tools at both the single center and national levels.
Study Type
Observational
Enrollment (Estimated)
5000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Crystee Cooper, DHEd
- Phone Number: 214-947-1280
- Email: ClinicalResearch@mhd.com
Study Contact Backup
- Name: Kavya Mankulangara
- Phone Number: 214-947-4604
- Email: ClinicalResearch@mhd.com
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75203
- Recruiting
- Methodist Dallas Medical Center- Clinical Research Institute
-
Contact:
- Kavya Mankulangara
- Phone Number: 214-947-4604
- Email: ClinicalResearch@mhd.com
-
Contact:
- Colette Ngo Ndjom
- Phone Number: 214-947-1289
- Email: ClinicalResearch@mhd.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
This observational trial will be limited by actual MDMC trauma patient volumes.
We anticipate one year of observations will be adequate to establish feedback on the efficacy of the activation criteria refinement.
We estimate this will include approximately 5,000 patient records.
Description
Inclusion Criteria:
Patient is included in the Methodist Dallas Medical Center trauma registry. Trauma patients who recieved care at Methodist Dallas Medical Center between November 24, 2023 and November 25, 2025.
Exclusion Criteria:
Patient does not meet registry inclusion criteria.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Methodist Dallas Medical Center trauma registry
Trauma patients who recieved care at Methodist Dallas Medical Center between November 24, 2023 and November 25, 2025.
|
To quantify the over- and under-triage rates as relative to trauma activation criteria reform.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Determine the over/under-triage rates
Time Frame: 2 year
|
The project will be evaluated by comparing the over- and under-triage rates of the historical criteria and the reformed criteria.
As the criteria reform was live November 25, 2024, pre-implementation will be defined as November 24, 2023 - November 24, 2024 and post-implementation will be defined as November 25, 2024 - November 25, 2025.
|
2 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jennifer Burris, MD, Methodist Health System
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 24, 2024
Primary Completion (Estimated)
November 24, 2027
Study Completion (Estimated)
November 1, 2028
Study Registration Dates
First Submitted
March 18, 2026
First Submitted That Met QC Criteria
March 18, 2026
First Posted (Actual)
March 24, 2026
Study Record Updates
Last Update Posted (Actual)
March 24, 2026
Last Update Submitted That Met QC Criteria
March 18, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 047.TRA.2024.D
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All information will be blinded in compliance with HIPAA(Health Insurance Portability and Accountability Act) regulations.
The investigator will make all possible efforts to ensure compliance with all policies regarding sharing of protected health information or research information.
Only de-identified protected health information will be shared in relevant research mediums.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Trauma
-
Humacyte, Inc.CompletedTrauma | Trauma Injury | Trauma, Multiple | Trauma BluntUkraine
-
Arrowhead Regional Medical CenterCompletedTrauma Injury | Trauma Blunt | Vascular TraumaUnited States
-
Prof. Dr. Cemil Tascıoglu Education and Research...CompletedTrauma Injury | Trauma, MultipleTurkey
-
University Hospital, AngersRecruiting
-
Wonju Severance Christian HospitalNational Research Foundation of KoreaCompletedTrauma Injury | Trauma, MultipleKorea, Republic of
-
Rabin Medical CenterIsraeli Ministry of SecurityUnknown
-
Hospital Departamental de VillavicencioCooperative University of Colombia; Clínica PrimaveraRecruitingTrauma Injury | Trauma Patients in ICU | Trauma (Including Fractures) | Trauma Patients | Trauma ICU PatientsColombia
-
Oslo University HospitalUniversity of Oslo; Sunnaas Rehabilitation Hospital; South-Eastern Norway Regional...RecruitingTrauma Injury | Trauma, Multiple | PolytraumaNorway
-
Chang, Steve S., M.D.Santa Barbara Cottage Hospital; Accumetrics, Inc.CompletedHead Injury Trauma BluntUnited States
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; Francophone Pediatric Resuscitation...Completed
Clinical Trials on over- and under-triage rates
-
Queen Mary University of LondonRoche Pharma AG; Barts & The London NHS TrustCompleted
-
ITGI MedicalUnknownDiseased Saphenous Vein Grafts | Aneurysmal Coronary ArteriesUnited Kingdom, Israel
-
Centre Hospitalier ArrasCompletedAcute Hypercapnic Respiratory FailureFrance
-
Università degli Studi di FerraraAalborg UniversityCompletedArtificial RespirationItaly
-
Duke UniversityThe John A. Hartford FoundationCompleted
-
Taipei Veterans General Hospital, TaiwanCompletedReadmission | Lumbar Spinal Fusion | Early DischargeTaiwan
-
Uşak UniversityCompleted
-
Abramson Cancer Center at Penn MedicineCompletedCancer | Solid Tumor | Telemedicine | Patient EmpowermentUnited States
-
University of Dublin, Trinity CollegeRoyal College of Surgeons, Ireland; Irish Cancer Society; National Cancer Control... and other collaboratorsCompleted
-
Instituto Nacional de Salud Publica, MexicoSecretaria de Salud, MexicoUnknownCervical Cancer | Intraepithelial NeoplasiaMexico